David T. Denhardt
Cell Biology & Neurosciences
Rutgers
The State University of New Jersey
Nelson Biology Laboratories
USA
Name/email consistency: high
- Commentary re: Q-T Le et al, identification of osteopontin as a prognostic marker for head and neck squamous cell carcinomas. clin cancer res, 9: 31-32, 2003. Denhardt, D.T. Clin. Cancer Res. (2003)
- Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter. Denhardt, D.T., Mistretta, D., Chambers, A.F., Krishna, S., Porter, J.F., Raghuram, S., Rittling, S.R. Clin. Exp. Metastasis (2003)
- Role of osteopontin in cellular signaling and toxicant injury. Denhardt, D.T., Giachelli, C.M., Rittling, S.R. Annu. Rev. Pharmacol. Toxicol. (2001)
- Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. Denhardt, D.T., Noda, M., O'Regan, A.W., Pavlin, D., Berman, J.S. J. Clin. Invest. (2001)
- Osteopontin-deficient bone cells are defective in their ability to produce NO in response to pulsatile fluid flow. Denhardt, D.T., Burger, E.H., Kazanecki, C., Krishna, S., Semeins, C.M., Klein-Nulend, J. Biochem. Biophys. Res. Commun. (2001)
- Osteopontin expression and function: role in bone remodeling. Denhardt, D.T., Noda, M. J. Cell. Biochem. Suppl. (1998)